Breaking News
November 17, 2018 - FDA announces new actions to limit sale of e-cigarettes to youth
November 17, 2018 - Warmer winter temperatures related to higher crime rates
November 17, 2018 - MCO places increasing emphasis on helping people find and access healthy food
November 17, 2018 - Group of students aim to improve malaria diagnosis using old smartphones
November 17, 2018 - Transplantation of feces may protect preterm children from deadly bowel disease
November 17, 2018 - Researchers explore whether low-gluten diets can be recommended for people without allergies
November 17, 2018 - New and better marker for assessing patients after cardiac arrest
November 17, 2018 - For 7-year-old with failing bone marrow, a life-saving transplant | News Center
November 17, 2018 - New first-line treatment for peripheral T-cell lymphoma approved by FDA
November 17, 2018 - Artificial intelligence could be valuable tool to help young victims disclose traumatic testimony
November 17, 2018 - Breakthrough in the treatment of Restless Legs Syndrome
November 16, 2018 - FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib
November 16, 2018 - Eagle Books | Native Diabetes Wellness Program
November 16, 2018 - Patients with common heart failure more likely to have lethal heart rhythms
November 16, 2018 - How AI could help veterinarians code their notes | News Center
November 16, 2018 - Bias-based bullying does more harm to students than generalized bullying
November 16, 2018 - Researchers find first direct evidence that cerebellum plays role in cognitive functions
November 16, 2018 - Non-coding genetic variant plays key role in endothelial function and disease incidence
November 16, 2018 - EMA recommends first all-oral treatment to tackle deadly sleeping sickness
November 16, 2018 - Drug used to treat dizziness may slow down growth of triple-negative breast cancer
November 16, 2018 - AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides
November 16, 2018 - ‘Orphan’ RNAs make cancer deadlier, but potentially easier to diagnose
November 16, 2018 - Air Cube touches down at hospital | News Center
November 16, 2018 - CRISPR-based tool shown to enhance cell-based immunotherapy
November 16, 2018 - Mechanisms that govern HIV latency differ in the gut and blood, finds study
November 16, 2018 - Researchers unravel mystery of NPM1 protein in acute myeloid leukemia
November 16, 2018 - High school students less likely to select milk, fruit for lunch when fruit juice is available
November 16, 2018 - Football coaches with great emotional competence are more successful
November 16, 2018 - Researchers awarded $10 million grant to address root causes of asthma in Puerto Rico
November 16, 2018 - Health Tip: Manage Morning Sickness
November 16, 2018 - Immunotherapy combination and chemotherapy show encouraging results in Phase II acute myeloid leukemia study
November 16, 2018 - ACC Latin America Conference brings experts to discuss latest cardiovascular science
November 16, 2018 - Pooled analysis of Intersect ENT’s steroid releasing implants in patients after frontal sinus surgery to be published
November 16, 2018 - Expectations about pain intensity can become self-fulfilling prophecies
November 16, 2018 - NIH awards $3.4 million to UC researchers to study gastrointestinal lymphatic system
November 16, 2018 - Highlighting Advances in Bioengineering and Analytical Technologies with eBooks
November 16, 2018 - Scientist Dr David Taylor of MR Solutions is a finalist in the BMW i UK Tech Founder Awards
November 16, 2018 - Earlier treatment could help reverse autistic-like behavior in tuberous sclerosis
November 16, 2018 - Sucking your baby’s pacifier could improve their health
November 16, 2018 - Vegetables and salad may include bacteria that are resistant to antibiotics
November 16, 2018 - Autism linked to prolonged connection between brain regions
November 16, 2018 - Endocrine Society chooses four Diabetes Caucus leaders as winners of Diabetes Champion Award
November 16, 2018 - Brain and muscle cells found within kidney organoids
November 16, 2018 - Person’s sex hormones may play key role in trauma survival, finds study
November 16, 2018 - PTEN Genetic Test: MedlinePlus Lab Test Information
November 16, 2018 - Toxic metal pollution linked with development of autism spectrum disorder
November 16, 2018 - Calcified nodules in the retina increase risk for progression to late stages of AMD
November 16, 2018 - ZEISS teams up with arivis AG to offer complete 3D imaging solutions
November 16, 2018 - Georgia State professor receives $1.2 million grant to study how the brain controls eating behavior
November 16, 2018 - Specific bacterial toxins reduce number of cells suppressing immune response
November 16, 2018 - Review by ID physician improves outcomes for outpatient parenteral antimicrobial therapy
November 16, 2018 - Conditions that produce signs similar to arthritis
November 16, 2018 - New artificial intelligence-based method predicts treatment effectiveness
November 16, 2018 - AHA: Dapagliflozin Noninferior to Placebo for MACE in T2DM
November 16, 2018 - Surgery remains best treatment for appendicitis, Stanford study finds
November 16, 2018 - Non-surgical fistula creation system Ellipsys becomes key focus of attention at CiDA
November 16, 2018 - Researchers find no link between ‘allergy friendly’ dogs and lower risk of asthma
November 16, 2018 - Researchers elucidate new rules of connectivity of neurons in the neocortex
November 16, 2018 - Treating children with ‘bubble baby disease’
November 16, 2018 - Nexus announces availability of Arsenic Trioxide Injection in the US
November 16, 2018 - Researchers find metabolite shuttle between cells in the liver that may combat tissue fibrosis
November 16, 2018 - AHA: PTSD Common Among Those Who Suffer Tear in the Aorta’s Wall
November 16, 2018 - Many RA patients’ pain related to central nervous system
November 16, 2018 - Changes in Himalayan gut microbiomes linked to diet
November 16, 2018 - Inhibition of prostaglandin E2 enhances ability to combat infectious colitis
November 16, 2018 - Chronic dry eye can slow reading rate and disrupt day to day tasks
November 16, 2018 - Researchers develop new drug molecule that inhibits inflammation
November 16, 2018 - Dementia symptoms peak in winter and spring, study finds
November 16, 2018 - Stanford tobacco researcher weighs in on JUUL
November 16, 2018 - Increasing omega-3 fatty acid intake during pregnancy reduces risk of premature birth, review finds
November 16, 2018 - Researchers find no link between infants waking up at night and later developmental problems
November 16, 2018 - Both parents and children agree about confidential medical services
November 16, 2018 - FDA warns against use of unapproved pain medications with implanted pumps
November 16, 2018 - Precision medicine-based approach to slow or reverse biologic drivers of Alzheimer’s disease
November 16, 2018 - Study provides new insight into norovirus outbreaks, may help guide efforts to develop vaccines
November 16, 2018 - Inexpensive, portable air purifier could help protect the heart from pollution
November 16, 2018 - New 15-minute scan could help diagnose brain damage in babies up to two years old
November 16, 2018 - Deep brain stimulation not effective for treating early Alzheimer’s
November 16, 2018 - Traditional chemotherapy superior to new alternative for oropharyngeal cancers | News Center
November 16, 2018 - What This Pond Protist Does With Its Genome Will Astound You
Breast Cancer as a Dynamic Disease

Breast Cancer as a Dynamic Disease

image_pdfDownload PDFimage_print

An interview with Dr. Andrew Ewald, Ph.D., discussing the influence of the myoepithelium on breast cancer growth and the importance of studying metastasis.

What is the tumor microenvironment and how is it linked to metastasis?

The tumor microenvironment is a general term describing all the things that are a part of the tumor but are not cancer cells. This includes healthy epithelial cells, cells of the immune system, blood vessels and the extracellular matrix (ECM); a scaffold of proteins that surrounds every tissue in the body, including tumors. The ECM also includes non-cellular features, such as the percentage of oxygen.

Cancer cell in tissue - Giovanni CancemiImage Credit: Giovanni Cancemi / Shutterstock

The tumor microenvironment is a hypoxic region containing a strong signaling group of cells that can withstand the mechanical forces and chemical signals surrounding the tumor.

This environment is important because it determines how the cancer cells will respond to treatment and thus, the prognosis of the disease. Patient outcomes are not just based on the size of the tumor and the number of mutations it contains. Instead, outcomes have a lot to do with the dialogue between cancer cells and the rest of the body, especially the cells and proteins found within the tumor microenvironment.

A central goal of my laboratory is to distinguish between promotion and resistance. We do this by building experimental systems in the laboratory wherein we can determine whether a given factor in the microenvironment is important or not in the growth of the tumor.

If a particular factor is found to be important for tumor growth, we might want to inhibit it. Equally, if a factor is inhibiting the growth of the tumor, we might want to strengthen its activity to prevent metastasis.

What is currently known about the breast cancer microenvironment and the stages of tissue invasion?

Breast cancer has two distinct forms; in situ and invasive. Ductal carcinoma in situ (DCIS), for example, is a fancy phrase for breast cancer cells that are surrounded by some of their normal tissue constraints. This includes myoepithelial cells and the basement membrane; a specialized set of proteins that surround the ducts of the breast.

As long as the cancer cells are inside both the myoepithelium and the basement membrane, the pathologist will diagnose it as ductal carcinoma in situ. Over 99% of these patients will have great outcomes.

Where it becomes challenging is when the cells have broken through the myoepithelium, which is clinically defined as invasive breast cancer. Whether or not the cancer cells have broken through the myoepithelium is the deciding feature between whether a diagnosis of DCIS or invasive breast cancer is made.

Regarding the breast cancer microenvironment, our lab and many others have proven on numerous occasions that the proteins surrounding the tumor are very important.

For example, collagen-1 is a very abundant protein in the human body. When a woman detects a lump in her breast, she’s feeling an abundance of collagen. This abundance is not like a couple of extra molecules – it is so much extra protein that it causes a lump. Work from labs such as Patricia Keely’s have shown that this collagen-1 is a very strong promoter of cancer invasion.

Our research has considered this as well. We recently showed that if you put cancer cells near collagen-1, they will align the collagen-1 into something resembling railroad tracks that they then use to migrate out of the tumor.

The myoepithelium, on the other hand, is resisting the invasion of the tumor. Therefore, if there is a myoepithelium, the cancer is not invasive, whereas if there is a break in the myoepithelium, the cancer cells migrate out into other tissues. We focused this project on trying to understand how that worked, how to think about it, and what we could do next.

Breast cancer cells undergoing metastasis through blood vessel - moving to another area of the body Giovanni CancemImage Credit: Giovanni Cancemi / Shutterstock

Please describe your recent research surrounding breast cancer.

We knew that the presence and integrity of the myoepithelial layer was the difference between a benign disease and an invasive one, but we wanted to understand how it worked.

We started by building 3D culture assays, which would allow us to grow whole tissues in the laboratory. You can think of tissue organization as being like raisins in a Jell-O mold; you have these structures growing within a three-dimensional environment of proteins.

We used various genetic tricks to visualize the cells that were trying to invade in one color and the myoepithelial cells in another color.

What was immediately striking was that the myoepithelium was actively responding to the invasive behavior of the cancer cells.

We would see the invasive cancer cells marching forward, and the myoepithelium reach out, recover them, and push them back inside. Most of the time, the myoepithelium would win.

Katarina Sirka

Real-time 3D confocal time-lapse movie of Twist1-expressing epithelial cells (red) invading into the surrounding extracellular matrix and then being restrained and pulled back by normal myoepithelial cells (green). Image Credit: Katarina Sirka.

Having seen this, we were really excited, but first, we needed to test whether this was a correlation or something that was causally related. We arranged different ratios of myoepithelial cells to invasive cells and were able to show that the more myoepithelial cells you had, the less invasion that occurred up to the point where you had a complete myoepithelial layer with essentially no invasion.

The next step was to understand the molecular basis of this interaction. We inhibited different pathways involved with either the adhesion between the myoepithelial cells or the contraction of the myoepithelial cells. Our results showed that both of those features, adhesion, and contraction, were required for the myoepithelium to act as a barrier to invasive behavior.

How do your findings differ to previous research, and what does this mean for patients?

How is it different? The analogy we like to use here is that people knew that the presence of the myoepithelium correlated with patient outcomes and that it was sufficient for a diagnosis of invasive breast cancer, but what they didn’t know was how those myoepithelial cells worked.

Before our research, it was possible this was purely a correlation. Ours is one of a very small number of papers that have tested whether the myoepithelial cells are functionally involved in resisting invasion, or whether they were just a good marker for the presence of invasion.

The most important concept that this paper introduces is the myoepithelium as a dynamic barrier. The analogy I like to use is between that of a castle wall. Imagine the outer wall in a castle; if that wall is breached, the invading army can simply run through it. There’s no further resistance from a wall after there’s a big hole in it.

However, what we showed is that the myoepithelium is better thought of as a soccer or football defense. The cancer cell can break though partially, but the myoepithelial cells will actively migrate, try to push it back inside.

The idea of a dynamic response to changes within a tissue is having an impact on research into other diseases. Scientists are now starting to consider the involvement of cells and epithelial barriers in a completely different way.

In answer to your second question, the key concept here is that we’ve increased our understanding of how the myoepithelium works and are now actively collaborating with pathologists to test whether we can leverage this understanding of how the myoepithelium works to provide a more individualized and personalized assessment of the risk of recurrence for women with breast cancer or DCIS.

What are the next steps for your research?

My laboratory studies metastasis; that’s the number one thing we’re interested in studying. We’re trying to understand how normal cells, through a series of mutations, acquire the ability to spread through the body, survive an unfamiliar environment, invade the immune system, and eventually grow tumors in distant organs.

We’re primarily focused on this question concerning breast cancer because it is in this disease that we think we could make the biggest and most immediate impact on patient outcomes with more research.

At the moment, we are trying to understand how the cells of the immune system interact with cancer cells as they’re spreading through the body.

We’re also working to understand the way in which molecular pathways in the cancer cell allow it to survive as it spreads through the body and transitions into a distant organ.

If we can understand all of this, and model the data using computational systems, we should be able to have a real impact on patient outcomes.

Where can readers find more information?

About Dr. Andrew Ewald

Dr. Ewald received his undergraduate degree in physics with honors from Haverford College. He earned his Ph.D. in biochemistry and molecular physics from the California Institute of Technology.

He completed postdoctoral work with Zena Werb in mammary biology and cancer at the University of California, San Francisco. Dr. Ewald joined the Johns Hopkins faculty in 2008.

He is a member of the American Association for Cancer Research, Society for Developmental Biology, and the American Society for Cell Biology.

Dr. Ewald’s work was recognized with the 2011 Morphological Sciences Award from the American Association of Anatomists for his contributions to the field of epithelial morphogenesis.

Tagged with:

About author

Related Articles